Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase

This study has been completed.

Study NCT00478647 Information provided by Shire Human Genetic Therapies, Inc.

First Received: May 23, 2007 Last Updated: August 14, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	August 2009
Primary Completion Date:	July 2009 (Final data collection date for primary outcome measure)